About V-Ensure Pharma Technologies Private Limited
Data last updated:
V-Ensure Pharma Technologies Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 26 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74990MH2010PTC205969. Its GSTIN is 27AADCV3743M1ZX (Maharashtra).
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹4.11 Cr. It is led by directors including Mousumi Satyanarayana Vemula and Sathyanarayana Vemula.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 63 Ttc Industrial Area MIDC Khairane, Navi Mumbai, Maharashtra, India – 400705.
As per the financials filed for FY 2025, the company reported a revenue of ₹77.73 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹4.51 Cr (net margin 5.8%) and EBITDA of ₹21.64 Cr (EBITDA margin 27.8%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years.
Its group structure includes 1 subsidiary.
The company is associated with 1 brand: V-Ensure Pharma Technologies. As per MCA filings, the company has open charges of ₹81.18 Cr and satisfied charges of ₹20.7 Cr on record. Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it. The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹130.29 Cr; the latest was in February 2022. Its 10 peer companies in the Pharma industry (API Manufacturers, Contract Research) are compared by revenue, 5 larger and 5 smaller; the largest is Nixi Laboratories Private Limited. The company has 8 MSME Form 1 returns on record between 2022 and 2024, listing 974 overdue payments to 61 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website v-ensure.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressA – 63 Ttc Industrial Area MIDC Khairane, Navi Mumbai, Maharashtra, India – 400705
- IndustryPharma, API Manufacturers, Pharma Contract R&D, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of V-Ensure Pharma Technologies Private Limited
The main business activity of V-Ensure Pharma Technologies is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of V-Ensure Pharma Technologies Private Limited FY 2025 filings available
V-Ensure Pharma Technologies Private Limited reported revenue of ₹77.73 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of V-Ensure Pharma Technologies Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 23% over three years, including 10% growth in the latest year. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of V-Ensure Pharma Technologies Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹21.64 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.51 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of V-Ensure Pharma Technologies Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 27.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of V-Ensure Pharma Technologies are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of V-Ensure Pharma Technologies Private Limited
V-Ensure Pharma Technologies Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers, Contract Research). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nixi Laboratories Private Limited | •••• | •••• | •••• | •••• | 29 | Nahan, Himachal Pradesh, India |
| Bioxera Pharma Private Limited | •••• | •••• | •••• | •••• | 88 | Mumbai, Maharashtra, India |
| Clarion Organics Limited | •••• | •••• | •••• | •••• | - | Bhandara, Maharashtra, India |
| Pratap Organics Private Limited | •••• | •••• | •••• | •••• | 72 | Navi Mumbai, Maharashtra, India |
| QPS Bioserve India Private Limited | •••• | •••• | •••• | •••• | 185 | Hyderabad, Telangana, India |
| V-Ensure Pharma Technologies Private Limited this company | •••• | •••• | •••• | •••• | - | Navi Mumbai, Maharashtra, India |
| Asence Pharma Private Limited | •••• | •••• | •••• | •••• | 77 | Vadodara, Gujarat, India |
| J P N Pharma Private Limited | •••• | •••• | •••• | •••• | 26 | Mumbai City, Maharashtra, India |
| Vimal Drugs Private Limited | •••• | •••• | •••• | •••• | 144 | Hyderabad, Telangana, India |
| Vineet Laboratories Limited Listed | •••• | •••• | •••• | •••• | 56 | Hyderabad, Telangana, India |
| Pentagon Labs Limited | •••• | •••• | •••• | •••• | - | Indore, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below V-Ensure Pharma Technologies by revenue in the Pharma industry (API Manufacturers, Contract Research), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of V-Ensure Pharma Technologies Private Limited
V-Ensure Pharma Technologies Private Limited is audited by S R B C & Co. LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S R B C & Co. LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors and KMP of V-Ensure Pharma Technologies Private Limited
V-Ensure Pharma Technologies Private Limited currently reports 3 directors and 1 key managerial person. 2 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashwin Savio Trinidad | Cfo | 14 Jun 2024 | 2 Years 3 Months | Current |
| Mousumi Satyanarayana Vemula Also directs: Skven Technologies Private Limited | Director | 26 Jul 2010 | 16 Years 2 Months | Current |
| Sathyanarayana Vemula | Director | 14 Mar 2020 | 6 Years 6 Months | Current |
| Gaurav Sharma Also directs: Prime Holdings Advisory LLP, Investcorp Investment Managers India LLP, Nephrocare Health Services Limited and 5 more | Director | 02 Feb 2022 | 4 Years 8 Months | Current |
Ownership and Shareholding of V-Ensure Pharma Technologies Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of V-Ensure Pharma Technologies Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Feb 2025 | Others | ₹15 Cr | Open |
| 20 Feb 2025 | Others | ₹10 Cr | Open |
| 20 Feb 2025 | Others | ₹11 Cr | Open |
| 03 Dec 2024 | Hdfc Bank Limited | ₹8.9 Lakh | Open |
| 03 Dec 2024 | Hdfc Bank Limited | ₹9.5 Lakh | Open |
Total charge records: 14 View all charges
Deals & Funding of V-Ensure Pharma Technologies Private Limited
V-Ensure Pharma Technologies Private Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹130.29 Cr; the latest was in February 2022.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2022 | Funding round | ₹130 Cr | Investors: Investcorp, Tanas Capital |
| Jan 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Mar 2015 | Funding round | ₹29 Lakh | Investors: 2 individuals |
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of V-Ensure Pharma Technologies Private Limited
V-Ensure Pharma Technologies Private Limited has 5 court cases on record: 1 filed by V-Ensure Pharma Technologies, 4 filed against it. All cases are disposed. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLAT | 5 | 4 | 0 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, New Delhi | Interim or miscellaneous application | Filed by the company against V-Ensure Pharma Technologies Private Limited | Disposed |
| NCLAT, New Delhi | Court case (Caveat) | Filed against the company by Elomatic Pharmalab Consultiing and Engineering Private Limited | Disposed |
| NCLAT, New Delhi | Interim or miscellaneous application | Filed against the company by Elomatic Pharmalab Consultiing and Engineering Private Limited | Disposed |
| NCLAT, New Delhi | Insolvency matter | Filed against the company by Elomatic Pharmalab Consultiing and Engineering Private Limited | Disposed |
Full case history
All 5 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by V-Ensure Pharma Technologies Private Limited
V-Ensure Pharma Technologies Private Limited has 8 MSME Form 1 returns on record between 2022 and 2024, listing 974 overdue payments to 61 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 61)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Satara Chemical Corporation (Partnership) | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Pacific Tools Private Limited | •••• | •••• | •••• |
| Synzeal Research Private Limited | •••• | •••• | •••• |
| National Chemical Co. | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 8 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with V-Ensure Pharma Technologies Private Limited
V-Ensure Pharma Technologies operates one associated brand: V-Ensure Pharma Technologies. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| APIs are manufactured by V-Ensure Pharma Technologies as a CDMO. | v-ensure.com |
Employees and EPFO Compliance at V-Ensure Pharma Technologies Private Limited
Employment history and EPFO contributions of people linked to V-Ensure Pharma Technologies.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of V-Ensure Pharma Technologies Private Limited
V-Ensure Pharma Technologies has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Skven Technologies Private Limited | U74999MH2014PTC256104 | Locked |
Showing major subsidiaries. Total: 1.
Recent Activity on V-Ensure Pharma Technologies Private Limited
V-Ensure Pharma Technologies Private Limited has 6 board changes on record since 2010: 4 appointments and 2 cessations. The latest: Ashwin Savio Trinidad was appointed as CFO on 14 Jun 2024.
24 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for V-Ensure Pharma Technologies Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of V-Ensure Pharma Technologies Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of V-Ensure Pharma Technologies Private Limited
V-Ensure Pharma Technologies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCV3743M1ZX | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of V-Ensure Pharma Technologies Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about V-Ensure Pharma Technologies Private Limited
V-Ensure Pharma Technologies is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 26 July 2010 (16+ years old) and is registered under CIN U74990MH2010PTC205969.
V-Ensure Pharma Technologies reported revenue of ₹77.73 Cr for FY 2025 (up 10% YoY).
V-Ensure Pharma Technologies has 4 current directors and KMP:
- Mousumi Satyanarayana Vemula - Director
- Sathyanarayana Vemula - Director
- Gaurav Sharma - Director
- Ashwin Savio Trinidad - Cfo
V-Ensure Pharma Technologies reported a net profit of ₹4.51 Cr (net margin 5.8%) and EBITDA of ₹21.64 Cr (EBITDA margin 27.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of V-Ensure Pharma Technologies is 23% over three years. In the latest year (FY 2025) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of V-Ensure Pharma Technologies is 27AADCV3743M1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of V-Ensure Pharma Technologies is U74990MH2010PTC205969. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
V-Ensure Pharma Technologies has 5 court cases on record: 1 filed by the company and 4 filed against it.
V-Ensure Pharma Technologies was incorporated on 26 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
V-Ensure Pharma Technologies has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹130.29 Cr; the latest was in February 2022.
The peers of V-Ensure Pharma Technologies by revenue are Nixi Laboratories Private Limited, Bioxera Pharma Private Limited, Clarion Organics Limited, Pratap Organics Private Limited, QPS Bioserve India Private Limited and 5 more, all in the Pharma industry (API Manufacturers, Contract Research).
Ashwin Savio Trinidad was appointed as CFO on 14 Jun 2024. Gaurav Sharma was appointed as Director on 02 Feb 2022. Sathyanarayana Vemula was appointed as Director on 14 Mar 2020. V-Ensure Pharma Technologies has 6 board changes on record in total.